Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21010

1.

New Advances In Atrial Fibrillation Management: The Role Of Apixaban.

Rosano GM, Spoletini I, Gianni W, Vitale C.

Curr Drug Targets. 2017 Oct 12. doi: 10.2174/1389450118666171013095413. [Epub ahead of print]

PMID:
29034832
2.

Novel Anticoagulant Therapy of Venous Thromboembolism: Current Status and Future Directions.

Nakamura M, Yamada N, Ito M.

Ann Vasc Dis. 2017 Jun 25;10(2):92-98. doi: 10.3400/avd.ra.17-00015. Review.

PMID:
29034033
3.

Acute Anorectal Thrombophlebitis Caused by a Protein C Deficiency.

Eso Y, Yoshiji S, Nakakubo Y, Matsuura M, Seno H.

Intern Med. 2017 Oct 16. doi: 10.2169/internalmedicine.9131-17. [Epub ahead of print]

PMID:
29033437
4.

Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non-Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke.

Kanai Y, Oguro H, Tahara N, Matsuda H, Takayoshi H, Mitaki S, Onoda K, Yamaguchi S.

J Stroke Cerebrovasc Dis. 2017 Oct 12. pii: S1052-3057(17)30478-0. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.007. [Epub ahead of print]

PMID:
29033229
5.

Surgery for acute type A aortic dissection on oral anticoagulants: Being the dispatcher of a 911 call.

Preventza O, Bracey A.

J Thorac Cardiovasc Surg. 2017 Sep 18. pii: S0022-5223(17)31945-1. doi: 10.1016/j.jtcvs.2017.09.028. [Epub ahead of print] No abstract available.

PMID:
29033036
6.

Evaluation of the predictive performance of bleeding risk scores in patients with non-valvular atrial fibrillation on oral anticoagulants.

Beshir SA, Aziz Z, Yap LB, Chee KH, Lo YL.

J Clin Pharm Ther. 2017 Oct 13. doi: 10.1111/jcpt.12634. [Epub ahead of print]

PMID:
29030869
7.

Off-Label Use of Direct Oral Anticoagulants in Intracerebral Hemorrhage Patients With Prosthetic Valves.

Chaturvedi S, Molina CA, Selim MH, Diener HC, Hohnloser SH.

Stroke. 2017 Oct 13. pii: STROKEAHA.117.017592. doi: 10.1161/STROKEAHA.117.017592. [Epub ahead of print] No abstract available.

PMID:
29030474
8.

Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis.

Boulouis G, Morotti A, Pasi M, Goldstein JN, Gurol ME, Charidimou A.

J Neurol Neurosurg Psychiatry. 2017 Oct 13. pii: jnnp-2017-316631. doi: 10.1136/jnnp-2017-316631. [Epub ahead of print]

PMID:
29030422
9.

Perioperative complications with new oral anticoagulants dabigatran, apixaban, and rivaroxaban in Mohs micrographic surgery: A retrospective study.

Antia C, Hone N, Gloster H.

J Am Acad Dermatol. 2017 Nov;77(5):967-968. doi: 10.1016/j.jaad.2017.05.038. No abstract available.

PMID:
29029905
10.

Anticoagulation in Pulmonary Embolism: Update in the Age of Direct Oral Anticoagulants.

Rosovsky R, Merli G.

Tech Vasc Interv Radiol. 2017 Sep;20(3):141-151. doi: 10.1053/j.tvir.2017.07.003. Epub 2017 Jul 5.

PMID:
29029708
11.

Mohs Micrographic Surgery: Key Pharmacologic Considerations.

Fischer D, Orlando P, Shane-McWhorter L.

Consult Pharm. 2017 Aug 1;32(8):450-457. doi: 10.4140/TCP.n.2017.450.

PMID:
29029665
12.
13.

High number of newly initiated direct oral anticoagulant users switch to alternate anticoagulant therapy.

Manzoor BS, Walton SM, Sharp LK, Galanter WL, Lee TA, Nutescu EA.

J Thromb Thrombolysis. 2017 Oct 12. doi: 10.1007/s11239-017-1565-2. [Epub ahead of print]

PMID:
29027097
14.

Treatment with direct oral anticoagulants in patients with upper extremity deep vein thrombosis.

Montiel FS, Ghazvinian R, Gottsäter A, Elf J.

Thromb J. 2017 Oct 3;15:26. doi: 10.1186/s12959-017-0149-x. eCollection 2017.

15.

Assessment of quality of life, satisfaction with anticoagulation therapy, and adherence to treatment in patients receiving long-course vitamin K antagonists or direct oral anticoagulants for venous thromboembolism.

Keita I, Aubin-Auger I, Lalanne C, Aubert JP, Chassany O, Duracinsky M, Mahé I.

Patient Prefer Adherence. 2017 Sep 25;11:1625-1634. doi: 10.2147/PPA.S131157. eCollection 2017.

16.

Clinical Prediction Model for Time in Therapeutic Range While on Warfarin in Newly Diagnosed Atrial Fibrillation.

Williams BA, Evans MA, Honushefsky AM, Berger PB.

J Am Heart Assoc. 2017 Oct 12;6(10). pii: e006669. doi: 10.1161/JAHA.117.006669.

17.

Acute and Recurrent Pericarditis.

Imazio M, Gaita F.

Cardiol Clin. 2017 Nov;35(4):505-513. doi: 10.1016/j.ccl.2017.07.004. Review.

PMID:
29025542
18.

Direct Oral Anticoagulants in Cardioversion: A Review of Current Evidence.

Gibson CM, Basto AN, Howard ML.

Ann Pharmacother. 2017 Oct 1:1060028017737095. doi: 10.1177/1060028017737095. [Epub ahead of print]

PMID:
29025267
19.

The tyranny of numbers, large and small.

Khaji A, Kowey PR.

J Cardiovasc Electrophysiol. 2017 Oct 11. doi: 10.1111/jce.13352. [Epub ahead of print] No abstract available.

PMID:
29024070
20.

Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis.

Gong X, Tang S, Li J, Zhang X, Tian X, Ma S.

PLoS One. 2017 Oct 12;12(10):e0186449. doi: 10.1371/journal.pone.0186449. eCollection 2017.

Supplemental Content

Loading ...
Support Center